{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:09:44Z","timestamp":1791389384896,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pandemic and epidemic outbreaks of influenza A virus (IAV) infection pose severe challenges to human society. Passive immunotherapy with recombinant neutralizing antibodies can potentially mitigate the threats of IAV infection. With a high throughput neutralizing antibody discovery platform, we produced artificial anti-hemagglutinin (HA) IAV-neutralizing IgGs from phage-displayed synthetic scFv libraries without necessitating prior memory of antibody-antigen interactions or relying on affinity maturation essential for\n                    <jats:italic>in vivo<\/jats:italic>\n                    immune systems to generate highly specific neutralizing antibodies. At least two thirds of the epitope groups of the artificial anti-HA antibodies resemble those of natural protective anti-HA antibodies, providing alternatives to neutralizing antibodies from natural antibody repertoires. With continuing advancement in designing and constructing synthetic scFv libraries, this technological platform is useful in mitigating not only the threats of IAV pandemics but also those from other newly emerging viral infections.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-14823-w","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T07:24:13Z","timestamp":1508916253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries"],"prefix":"10.1038","volume":"7","author":[{"given":"Ing-Chien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Kai","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-3167","authenticated-orcid":false,"given":"Chao-Ping","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Liang","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Sen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.-J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Suei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"14823_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/vaccines3020239","volume":"3","author":"LC Wiersma","year":"2015","unstructured":"Wiersma, L. C., Rimmelzwaan, G. F. & de Vries, R. D. Developing universal influenza vaccines: hitting the nail, not just on the head. Vaccines \n                           3, 239\u2013262, https:\/\/doi.org\/10.3390\/vaccines3020239 (2015).","journal-title":"Vaccines"},{"key":"14823_CR2","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","volume":"25","author":"NA Molinari","year":"2007","unstructured":"Molinari, N. A. et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine \n                           25, 5086\u20135096, https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.046 (2007).","journal-title":"Vaccine"},{"key":"14823_CR3","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1586\/14787210.2014.966083","volume":"12","author":"N Spanakis","year":"2014","unstructured":"Spanakis, N., Pitiriga, V., Gennimata, V. & Tsakris, A. A review of neuraminidase inhibitor susceptibility in influenza strains. Expert Rev. Anti. Infect. Ther. \n                           12, 1325\u20131336, https:\/\/doi.org\/10.1586\/14787210.2014.966083 (2014).","journal-title":"Expert Rev. Anti. Infect. Ther."},{"issue":"Suppl 3","key":"14823_CR4","first-page":"16","volume":"125","author":"JK Taubenberger","year":"2010","unstructured":"Taubenberger, J. K. & Morens, D. M. Influenza: the once and future pandemic. Public Health Rep. \n                           125(Suppl 3), 16\u201326 (2010).","journal-title":"Public Health Rep."},{"key":"14823_CR5","doi-asserted-by":"publisher","first-page":"805306","DOI":"10.1155\/2015\/805306","volume":"2015","author":"JH Lin","year":"2015","unstructured":"Lin, J. H. & Wu, H. S. Challenges and strategies of laboratory diagnosis for newly emerging influenza viruses in Taiwan: a decade after SARS. BioMed. Res. Int. \n                           2015, 805306, https:\/\/doi.org\/10.1155\/2015\/805306 (2015).","journal-title":"BioMed. Res. Int."},{"key":"14823_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/vaccines3010172","volume":"3","author":"C Trombetta","year":"2015","unstructured":"Trombetta, C., Piccirella, S., Perini, D., Kistner, O. & Montomoli, E. Emerging influenza strains in the last two decades: a threat of a new pandemic? Vaccines \n                           3, 172\u2013185, https:\/\/doi.org\/10.3390\/vaccines3010172 (2015).","journal-title":"Vaccines"},{"key":"14823_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"J Sui","year":"2009","unstructured":"Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. \n                           16, 265\u2013273 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"14823_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science \n                           324, 246\u2013251, https:\/\/doi.org\/10.1126\/science.1171491 (2009).","journal-title":"Science"},{"key":"14823_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature12379","volume":"499","author":"J Zhou","year":"2013","unstructured":"Zhou, J. et al. Biological features of novel avian influenza A (H7N9) virus. Nature \n                           499, 500\u2013503, https:\/\/doi.org\/10.1038\/nature12379 (2013).","journal-title":"Nature"},{"key":"14823_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1243325","volume":"341","author":"RA Fouchier","year":"2013","unstructured":"Fouchier, R. A. et al. Gain-of-function experiments on H7N9. Science \n                           341, 612\u2013613, https:\/\/doi.org\/10.1126\/science.1243325 (2013).","journal-title":"Science"},{"key":"14823_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.1242917","volume":"342","author":"Y Shi","year":"2013","unstructured":"Shi, Y. et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science \n                           342, 243\u2013247, https:\/\/doi.org\/10.1126\/science.1242917 (2013).","journal-title":"Science"},{"key":"14823_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nrmicro3362","volume":"12","author":"Y Shi","year":"2014","unstructured":"Shi, Y., Wu, Y., Zhang, W., Qi, J. & Gao, G. F. Enabling the \u2018host jump\u2019: structural determinants of receptor-binding specificity in influenza A viruses. Nat. Rev. Microbiol. \n                           12, 822\u2013831, https:\/\/doi.org\/10.1038\/nrmicro3362 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"14823_CR13","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","volume":"34","author":"F Berlanda Scorza","year":"2016","unstructured":"Berlanda Scorza, F., Tsvetnitsky, V. & Donnelly, J. J. Universal influenza vaccines: Shifting to better vaccines. Vaccine \n                           34, 2926\u20132933, https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.085 (2016).","journal-title":"Vaccine"},{"key":"14823_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug. Discov. \n                           14, 167\u2013182, https:\/\/doi.org\/10.1038\/nrd4529 (2015).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"14823_CR15","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1016\/j.vaccine.2016.08.057","volume":"34","author":"E Sparrow","year":"2016","unstructured":"Sparrow, E., Friede, M., Sheikh, M., Torvaldsen, S. & Newall, A. T. Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine \n                           34, 5442\u20135448, https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.057 (2016).","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"14823_CR16","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.cmi.2015.12.005","volume":"22","author":"RD de Vries","year":"2016","unstructured":"de Vries, R. D., Altenburg, A. F. & Rimmelzwaan, G. F. Universal influenza vaccines: a realistic option? Clin. Microbiol. Infect. \n                           22(Suppl 5), S120\u2013S124, https:\/\/doi.org\/10.1016\/j.cmi.2015.12.005 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"14823_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3201\/eid2206.151037","volume":"22","author":"AC Hurt","year":"2016","unstructured":"Hurt, A. C. & Kelly, H. Debate regarding oseltamivir use for seasonal and pandemic influenza. Emerg. Infect. Dis. \n                           22, 949\u2013955, https:\/\/doi.org\/10.3201\/eid2206.151037 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"14823_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","volume":"67","author":"E van der Vries","year":"2013","unstructured":"van der Vries, E., Schutten, M., Fraaij, P., Boucher, C. & Osterhaus, A. Influenza virus resistance to antiviral therapy. Adv. Pharmacol. \n                           67, 217\u2013246, https:\/\/doi.org\/10.1016\/b978-0-12-405880-4.00006-8 (2013).","journal-title":"Adv. Pharmacol."},{"key":"14823_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2016.05.012","volume":"42","author":"KE Neu","year":"2016","unstructured":"Neu, K. E., Henry Dunand, C. J. & Wilson, P. C. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr. Opin. Iimmunol. \n                           42, 48\u201355, https:\/\/doi.org\/10.1016\/j.coi.2016.05.012 (2016).","journal-title":"Curr. Opin. Iimmunol."},{"key":"14823_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","volume":"30","author":"L Naesens","year":"2016","unstructured":"Naesens, L., Stevaert, A. & Vanderlinden, E. Antiviral therapies on the horizon for influenza. Curr. Opin. Pharmacol. \n                           30, 106\u2013115, https:\/\/doi.org\/10.1016\/j.coph.2016.08.003 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"key":"14823_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coviro.2016.03.002","volume":"17","author":"A Cho","year":"2016","unstructured":"Cho, A. & Wrammert, J. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Curr. Opin. Virol. \n                           17, 110\u2013115, https:\/\/doi.org\/10.1016\/j.coviro.2016.03.002 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"14823_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2015.00315","volume":"6","author":"Z Shriver","year":"2015","unstructured":"Shriver, Z., Trevejo, J. M. & Sasisekharan, R. Antibody-based strategies to prevent and treat influenza. Front. Immunol. \n                           6, 315, https:\/\/doi.org\/10.3389\/fimmu.2015.00315 (2015).","journal-title":"Front. Immunol."},{"key":"14823_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.coviro.2015.03.006","volume":"11","author":"GM Air","year":"2015","unstructured":"Air, G. M. Influenza virus antigenicity and broadly neutralizing epitopes. Curr. Opin. Virol. \n                           11, 113\u2013121, https:\/\/doi.org\/10.1016\/j.coviro.2015.03.006 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"14823_CR24","doi-asserted-by":"publisher","first-page":"267594","DOI":"10.1155\/2014\/267594","volume":"2014","author":"CM Berry","year":"2014","unstructured":"Berry, C. M., Penhale, W. J. & Sangster, M. Y. Passive broad-spectrum influenza immunoprophylaxis. Influenza Res. Ttreat. \n                           2014, 267594, https:\/\/doi.org\/10.1155\/2014\/267594 (2014).","journal-title":"Influenza Res. Ttreat."},{"key":"14823_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/med.21289","volume":"34","author":"E Vanderlinden","year":"2013","unstructured":"Vanderlinden, E. & Naesens, L. Emerging antiviral strategies to interfere with influenza virus entry. Med. Res. Rev. \n                           34, 301\u2013339, https:\/\/doi.org\/10.1002\/med.21289 (2013).","journal-title":"Med. Res. Rev."},{"key":"14823_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.antiviral.2013.03.021","volume":"98","author":"NS Laursen","year":"2013","unstructured":"Laursen, N. S. & Wilson, I. A. Broadly neutralizing antibodies against influenza viruses. Antiviral Res. \n                           98, 476\u2013483, https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.021 (2013).","journal-title":"Antiviral Res."},{"key":"14823_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","volume":"31","author":"D Corti","year":"2013","unstructured":"Corti, D. & Lanzavecchia, A. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. \n                           31, 705\u2013742, https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095916 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"14823_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00218-17","author":"TP Peacock","year":"2017","unstructured":"Peacock, T. P. et al. Immune escape variants of H9N2 influenza viruses containing deletions at the haemagglutinin receptor binding site retain fitness in vivo and display enhanced zoonotic characteristics. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00218-17 (2017).","journal-title":"J. Virol"},{"key":"14823_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep12411","volume":"5","author":"HS Chen","year":"2015","unstructured":"Chen, H. S. et al. Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens. Sci. Rep. \n                           5, 12411, https:\/\/doi.org\/10.1038\/srep12411 (2015).","journal-title":"Sci. Rep."},{"key":"14823_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nri.2016.67","volume":"16","author":"RA Lerner","year":"2016","unstructured":"Lerner, R. A. Combinatorial antibody libraries: new advances, new immunological insights. Nat. Rev. Immunol. \n                           16, 498\u2013508, https:\/\/doi.org\/10.1038\/nri.2016.67 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"14823_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep31878","volume":"6","author":"SC Hou","year":"2016","unstructured":"Hou, S. C. et al. High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries. Sci. Rep. \n                           6, 31878, https:\/\/doi.org\/10.1038\/srep31878 (2016).","journal-title":"Sci. Rep."},{"key":"14823_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep15053","volume":"5","author":"CP Tung","year":"2015","unstructured":"Tung, C. P. et al. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries. Sci. Rep. \n                           5, 15053, https:\/\/doi.org\/10.1038\/srep15053 (2015).","journal-title":"Sci. Rep."},{"key":"14823_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/371037a0","volume":"371","author":"PA Bullough","year":"1994","unstructured":"Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature \n                           371, 37\u201343, https:\/\/doi.org\/10.1038\/371037a0 (1994).","journal-title":"Nature"},{"key":"14823_CR34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science \n                           333, 850\u2013856, https:\/\/doi.org\/10.1126\/science.1205669 (2011).","journal-title":"Science"},{"key":"14823_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/82_2014_413","volume":"386","author":"PS Lee","year":"2015","unstructured":"Lee, P. S. & Wilson, I. A. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr. Top. Microbiol. Immunol. \n                           386, 323\u2013341, https:\/\/doi.org\/10.1007\/82_2014_413 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"14823_CR36","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.1118979109","volume":"109","author":"GM Li","year":"2012","unstructured":"Li, G. M. et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA \n                           109, 9047\u20139052, https:\/\/doi.org\/10.1073\/pnas.1118979109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14823_CR37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science \n                           337, 1343\u20131348, https:\/\/doi.org\/10.1126\/science.1222908 (2012).","journal-title":"Science"},{"key":"14823_CR38","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. \n                           22, 1456\u20131464, https:\/\/doi.org\/10.1038\/nm.4224 (2016).","journal-title":"Nat. Med."},{"key":"14823_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.str.2013.10.006","volume":"22","author":"HJ Hsu","year":"2014","unstructured":"Hsu, H. J. et al. Antibody variable domain interface and framework sequence requirements for stability and function by high-throughput experiments. Structure \n                           22, 22\u201334, https:\/\/doi.org\/10.1016\/j.str.2013.10.006 (2014).","journal-title":"Structure"},{"key":"14823_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.str.2013.10.005","volume":"22","author":"HJ Chang","year":"2014","unstructured":"Chang, H. J. et al. Loop-sequence features and stability determinants in antibody variable domains by high-throughput experiments. Structure \n                           22, 9\u201321, https:\/\/doi.org\/10.1016\/j.str.2013.10.005 (2014).","journal-title":"Structure"},{"key":"14823_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature \n                           489, 526\u2013532, https:\/\/doi.org\/10.1038\/nature11414 (2012).","journal-title":"Nature"},{"key":"14823_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science \n                           333, 843\u2013850, https:\/\/doi.org\/10.1126\/science.1204839 (2011).","journal-title":"Science"},{"key":"14823_CR43","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1073\/pnas.0806901105","volume":"105","author":"MW Chen","year":"2008","unstructured":"Chen, M. W. et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc. Natl. Acad. Sci. USA \n                           105, 13538\u201313543, https:\/\/doi.org\/10.1073\/pnas.0806901105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14823_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. \n                           276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"14823_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. \n                           67, 235\u2013242, https:\/\/doi.org\/10.1107\/S0907444910045749 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"14823_CR46","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. \n                           60, 2126\u20132132, https:\/\/doi.org\/10.1107\/S0907444904019158 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"14823_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. \n                           67, 355\u2013367, https:\/\/doi.org\/10.1107\/S0907444911001314 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"14823_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. \n                           25, 1605\u20131612, https:\/\/doi.org\/10.1002\/jcc.20084 (2004).","journal-title":"J. Comput. Chem."},{"key":"14823_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1538\/expanim.14-0059","volume":"64","author":"CS Kue","year":"2015","unstructured":"Kue, C. S., Tan, K. Y., Lam, M. L. & Lee, H. B. Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp. Anim. \n                           64, 129\u2013138, https:\/\/doi.org\/10.1538\/expanim.14-0059 (2015).","journal-title":"Exp. Anim."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14823-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:00:27Z","timestamp":1671782427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14823"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14823-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732062400.793549203","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]},"assertion":[{"value":"15 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14455"}}